Department of Gastroenterological Surgery, The Affiliated Hospital of Jiaxing University, Zhejiang, China.
Genet Test Mol Biomarkers. 2020 Dec;24(12):835-844. doi: 10.1089/gtmb.2020.0099. Epub 2020 Dec 7.
The selenoprotein S () gene has been suggested to be an important factor in the development of multiple diseases, including gastric cancer (GC) and colorectal cancer (CRC). However, the association between the gene rs34713741 polymorphism and risk of GC and CRC is inconclusive. Thus, we aimed to investigate the relationship between this polymorphism and the susceptibility to GC and CRC through a meta-analysis. Literature was retrieved through the following electronic databases: PubMed, Embase, Web of Science, and Chinese National Knowledge Infrastructure. The pooled odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of the associations of the alleles of rs4713741 locus with the risk of CRC and GC. Seven studies that collectively included 2331 cases and 2233 controls were utilized for this meta-analysis. Under the allelic and dominant models, the T allele of the rs34713741 polymorphism was significantly associated with CRC risk (allelic model: OR = 1.20, 95% CI = 1.08-1.33, = 0.0004; dominant model: OR = 1.25, 95% CI = 1.10-1.43, = 0.001). In addition, all of the genetic models (allelic, dominant, and recessive models) identified the rs34713741 T allele as being significantly associated with GC risk (allelic model: OR = 1.67, 95% CI = 1.30-2.15, < 0.001; dominant model: OR = 1.70, 95% CI = 1.25-2.30, = 0.0006; recessive model: OR = 2.39, 95% CI = 1.26-4.50, = 0.007). The gene rs34713741 T-allele is a highly probable risk factor for both CRC and GC. The results of this study will provide support for using this single nucleotide polymorphism in the diagnosis of GC and CRC.
硒蛋白 S () 基因被认为是多种疾病(包括胃癌 (GC) 和结直肠癌 (CRC))发展的重要因素。然而,基因 rs34713741 多态性与 GC 和 CRC 风险之间的关联尚无定论。因此,我们旨在通过荟萃分析研究这种多态性与 GC 和 CRC 易感性之间的关系。通过以下电子数据库检索文献:PubMed、Embase、Web of Science 和中国国家知识基础设施。使用合并的优势比 (OR) 和 95%置信区间 (CI) 来评估 rs4713741 位点等位基因与 CRC 和 GC 风险的关联强度。这项荟萃分析共纳入了 7 项研究,共包括 2331 例病例和 2233 例对照。在等位基因和显性模型下,基因 rs34713741 的 T 等位基因与 CRC 风险显著相关(等位基因模型:OR=1.20,95%CI=1.08-1.33, =0.0004;显性模型:OR=1.25,95%CI=1.10-1.43, =0.001)。此外,所有遗传模型(等位基因、显性和隐性模型)都发现基因 rs34713741 的 T 等位基因与 GC 风险显著相关(等位基因模型:OR=1.67,95%CI=1.30-2.15, <0.001;显性模型:OR=1.70,95%CI=1.25-2.30, =0.0006;隐性模型:OR=2.39,95%CI=1.26-4.50, =0.007)。基因 rs34713741 的 T 等位基因是 CRC 和 GC 的一个高度可能的危险因素。本研究结果将为使用这种单核苷酸多态性诊断 GC 和 CRC 提供支持。